DIRECT application of brain-derived neurotrophic factor (BDNF) to the
cut end of axotomized immature motor neurones had only transient survi
val-promoting effects. Therefore, we have examined whether additional
delivery of BDNF with repeated subcutaneous injections (1 mg/ml) could
potentiate this short-term rescue of the lesioned sciatic and facial
motor neurones in neonatal rats. Direct application of BDNF combined w
ith intermittent (3-day intervals) injections slightly improved motor
neurone survival. However, when BDNF was injected daily in addition to
the direct application, the number of surviving lesioned motor neuron
es was markedly reduced. These findings, corroborated by results in em
bryonic spinal cord cultures, show that a dose-dependent reversal of B
DNF-mediated positive effects on motor neurones occurs in vivo.